Literature DB >> 10952240

Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride.

T Watanabe1, M Niioka, S Hozawa, K Kameyama, T Hayashi, M Arai, A Ishikawa, K Maruyama, I Okazaki.   

Abstract

BACKGROUND/AIMS: Liver fibrosis is a dynamic state between matrix production and degradation. Since our report in 1974, many studies have examined collagenase and liver fibrosis, but not the identification of cells responsible for collagenase production in vivo. The aim of this study was to investigate the gene expression of interstitial collagenase in the progressive and recovery phases of experimental rat liver fibrosis by in situ hybridization.
METHODS: We examined the gene expression of interstitial collagenase (MMP-13) in the progressive and recovery phase of experimental rat liver fibrosis induced by chronic CCl4 intoxication by reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization. In order to identify the cells expressing MMP-13 mRNA by in situ hybridization, immunohistochemistry was performed using serial sections.
RESULTS: In normal rat liver, a faint band for MMP-13 mRNA was observed by RT-PCR, but not by in situ hybridization. The livers of rats treated with CCl4 for 4 weeks showed fatty metamorphosis but no definite fibrosis. Positive signals for MMP-13 mRNA were observed in scattered mesenchymal cells, within lobules which seem to be stellate cells from immunohistochemical staining. Once the fibrosis became prominent, the faint band for MMP-13 mRNA was detected only by RT-PCR and very few signals, if any, by in situ hybridization. On the other hand, in the recovery phase of liver fibrosis, gene expression of MMP-13 was markedly enhanced. Strong positive cells by in situ hybridization were observed mainly at the interface between the resolving fibrous septa and the parenchyma. Overlapping both images of in situ hybridization and immunohistochemical staining with the help of a computer revealed that some positive cells, but not all cells, were stellate cells stained with a-smooth muscle actin antibody.
CONCLUSIONS: MMP-13 participates in the degradation of newly-formed matrix in the recovery from rat liver fibrosis more than in the remodeling of extracellular matrix for the formation of fibrosis. Hepatic stellate cells play a crucial role in MMP-13 production in the recovery from fibrosis, though not all stellate cells were positive for MMP-13 mRNA. Further investigation into gene expression of MMP-13 in recovery will lead to new strategies for the treatment of liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952240     DOI: 10.1016/s0168-8278(00)80363-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

1.  Extracellular matrix bioengineering and systems biology approaches in liver disease.

Authors:  Natalia Nieto; Matthias P Lutolf
Journal:  Syst Synth Biol       Date:  2011-06-17

2.  Zinc mediated hepatic stellate cell collagen synthesis reduction through TGF-β signaling pathway inhibition.

Authors:  Min Kang; Lei Zhao; Meiping Ren; Mingming Deng; Changping Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation.

Authors:  Masaaki Sato; David M Hwang; Zehong Guan; Jonathan C Yeung; Masaki Anraku; Dirk Wagnetz; Shin Hirayama; Thomas K Waddell; Mingyao Liu; Shaf Keshavjee
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

Review 4.  Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

5.  Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid.

Authors:  Eun-Joong Kim; Hee-Jeong Cho; Daeui Park; Ji Yeon Kim; Young Bong Kim; Tae Gwan Park; Chang-Koo Shim; Yu-Kyoung Oh
Journal:  Mol Ther       Date:  2010-12-07       Impact factor: 11.454

6.  Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

Authors:  Ping Liu; Yi-Yang Hu; Cheng Liu; Da-Yuan Zhu; Hui-Ming Xue; Zhi-Qiang Xu; Lie-Ming Xu; Cheng-Hai Liu; Hong-Tu Gu; Zhi-Qing Zhang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

8.  Effects of heparin on liver fibrosis in patients with chronic hepatitis B.

Authors:  Jun Shi; Jing-Hua Hao; Wan-Hua Ren; Ju-Ren Zhu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

9.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

10.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.